Results
|
101.
|
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. [electronic resource] by
- Underwood, D C
- Osborn, R R
- Bochnowicz, S
- Webb, E F
- Rieman, D J
- Lee, J C
- Romanic, A M
- Adams, J L
- Hay, D W
- Griswold, D E
Producer: 20001109
In:
American journal of physiology. Lung cellular and molecular physiology vol. 279
Availability: No items available.
|
|
102.
|
Pharmacologic profile of SK&F 104353, a novel, highly potent and selective peptidoleukotriene antagonist. [electronic resource] by
- Wasserman, M A
- Torphy, T J
- Hay, D W
- Muccitelli, R M
- Tucker, S S
- Wilson, K A
- Osborn, R R
- Vickery-Clark, L
- Hall, R F
- Erhard, K F
Producer: 19871119
In:
Advances in prostaglandin, thromboxane, and leukotriene research vol. 17A
Availability: No items available.
|
|
103.
|
Pharmacologic and pharmacokinetic profile of SK&F S-106203, a potent, orally active peptidoleukotriene receptor antagonist, in guinea-pig. [electronic resource] by
- Hay, D W
- Muccitelli, R M
- Vickery-Clark, L M
- Novak, L S
- Osborn, R R
- Gleason, J G
- Yodis, L A
- Saverino, C M
- Eckardt, R D
- Sarau, H M
Producer: 19920819
In:
Pulmonary pharmacology vol. 4
Availability: No items available.
|
|
104.
|
Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthma. [electronic resource] by
- Chabot-Fletcher, M C
- Underwood, D C
- Breton, J J
- Adams, J L
- Kagey-Sobotka, A
- Griswold, D E
- Marshall, L A
- Sarau, H M
- Winkler, J D
- Hay, D W
Producer: 19950721
In:
The Journal of pharmacology and experimental therapeutics vol. 273
Availability: No items available.
|
|
105.
|
2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor. [electronic resource] by
- Giardina, G A
- Sarau, H M
- Farina, C
- Medhurst, A D
- Grugni, M
- Foley, J J
- Raveglia, L F
- Schmidt, D B
- Rigolio, R
- Vassallo, M
- Vecchietti, V
- Hay, D W
Producer: 19960823
In:
Journal of medicinal chemistry vol. 39
Availability: No items available.
|
|
106.
|
SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. [electronic resource] by
- Underwood, D C
- Osborn, R R
- Kotzer, C J
- Adams, J L
- Lee, J C
- Webb, E F
- Carpenter, D C
- Bochnowicz, S
- Thomas, H C
- Hay, D W
- Griswold, D E
Producer: 20000421
In:
The Journal of pharmacology and experimental therapeutics vol. 293
Availability: No items available.
|
|
107.
|
Polymorphisms in the endothelin-1 (EDN1) are associated with asthma in two populations. [electronic resource] by
- Zhu, G
- Carlsen, K
- Carlsen, K-H
- Lenney, W
- Silverman, M
- Whyte, M K
- Hosking, L
- Helms, P
- Roses, A D
- Hay, D W
- Barnes, M R
- Anderson, W H
- Pillai, S G
Producer: 20080327
In:
Genes and immunity vol. 9
Availability: No items available.
|
|
108.
|
Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412). [electronic resource] by
- Giardina, G A
- Raveglia, L F
- Grugni, M
- Sarau, H M
- Farina, C
- Medhurst, A D
- Graziani, D
- Schmidt, D B
- Rigolio, R
- Luttmann, M
- Cavagnera, S
- Foley, J J
- Vecchietti, V
- Hay, D W
Producer: 19990413
In:
Journal of medicinal chemistry vol. 42
Availability: No items available.
|
|
109.
|
Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonist. [electronic resource] by
- Sarau, H M
- Griswold, D E
- Potts, W
- Foley, J J
- Schmidt, D B
- Webb, E F
- Martin, L D
- Brawner, M E
- Elshourbagy, N A
- Medhurst, A D
- Giardina, G A
- Hay, D W
Producer: 19970721
In:
The Journal of pharmacology and experimental therapeutics vol. 281
Availability: No items available.
|
|
110.
|
Molecular and pharmacological characterization of the murine tachykinin NK(3) receptor. [electronic resource] by
- Sarau, H M
- Feild, J A
- Ames, R S
- Foley, J J
- Nuthulaganti, P
- Schmidt, D B
- Buckley, P T
- Elshourbagy, N A
- Brawner, M E
- Luttmann, M A
- Giardina, G A
- Hay, D W
Producer: 20010531
In:
European journal of pharmacology vol. 413
Availability: No items available.
|
|
111.
|
Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists. [electronic resource] by
- Giardina, G A
- Artico, M
- Cavagnera, S
- Cerri, A
- Consolandi, E
- Gagliardi, S
- Graziani, D
- Grugni, M
- Hay, D W
- Luttmann, M A
- Mena, R
- Raveglia, L F
- Rigolio, R
- Sarau, H M
- Schmidt, D B
- Zanoni, G
- Farina, C
Producer: 19991110
In:
Farmaco (Societa chimica italiana : 1989) vol. 54
Availability: No items available.
|
|
112.
|
Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists. [electronic resource] by
- Blaney, F E
- Raveglia, L F
- Artico, M
- Cavagnera, S
- Dartois, C
- Farina, C
- Grugni, M
- Gagliardi, S
- Luttmann, M A
- Martinelli, M
- Nadler, G M
- Parini, C
- Petrillo, P
- Sarau, H M
- Scheideler, M A
- Hay, D W
- Giardina, G A
Producer: 20010614
In:
Journal of medicinal chemistry vol. 44
Availability: No items available.
|
|
113.
|
Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist. [electronic resource] by
- Sarau, H M
- Griswold, D E
- Bush, B
- Potts, W
- Sandhu, P
- Lundberg, D
- Foley, J J
- Schmidt, D B
- Webb, E F
- Martin, L D
- Legos, J J
- Whitmore, R G
- Barone, F C
- Medhurst, A D
- Luttmann, M A
- Giardina, G A
- Hay, D W
Producer: 20001103
In:
The Journal of pharmacology and experimental therapeutics vol. 295
Availability: No items available.
|
|
114.
|
In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity. [electronic resource] by
- Sarau, H M
- Foley, J J
- Schmidt, D B
- Martin, L D
- Webb, E F
- Tzimas, M N
- Breton, J J
- Chabot-Fletcher, M
- Underwood, D C
- Hay, D W
- Kingsbury, W D
- Chambers, P A
- Pendrak, I
- Jakas, D R
- Sathe, G M
- Van Horn, S
- Daines, R A
- Griswold, D E
Producer: 19991007
In:
Prostaglandins, leukotrienes, and essential fatty acids vol. 61
Availability: No items available.
|
|
115.
|
Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. [electronic resource] by
- Sarau, H M
- Ames, R S
- Chambers, J
- Ellis, C
- Elshourbagy, N
- Foley, J J
- Schmidt, D B
- Muccitelli, R M
- Jenkins, O
- Murdock, P R
- Herrity, N C
- Halsey, W
- Sathe, G
- Muir, A I
- Nuthulaganti, P
- Dytko, G M
- Buckley, P T
- Wilson, S
- Bergsma, D J
- Hay, D W
Producer: 19990914
In:
Molecular pharmacology vol. 56
Availability: No items available.
|
|
116.
|
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. [electronic resource] by
- Ames, R S
- Sarau, H M
- Chambers, J K
- Willette, R N
- Aiyar, N V
- Romanic, A M
- Louden, C S
- Foley, J J
- Sauermelch, C F
- Coatney, R W
- Ao, Z
- Disa, J
- Holmes, S D
- Stadel, J M
- Martin, J D
- Liu, W S
- Glover, G I
- Wilson, S
- McNulty, D E
- Ellis, C E
- Elshourbagy, N A
- Shabon, U
- Trill, J J
- Hay, D W
- Ohlstein, E H
- Bergsma, D J
- Douglas, S A
Producer: 19991014
In:
Nature vol. 401
Availability: No items available.
|